Myeloma Institute for Research and Therapy
University of Arkansas For Medical Sciences, USA
Assistant Professor
E-mail: [email protected]
Qualifications
2006 Ph.D., Dept. of Immunology, University of Texas MD Anderson Cancer Center, USA
1997 M.Ag., Dept. of Animal and Dairy Sciences, Auburn University, USA
1990 B.Sc., Dept. of Genetic Engineering, Sung Kyung Kwan University, Korea
Publications(Selected)
-
Bennink, L.L., Li, Y., Kim, B., Shin, I.J.,
San, B.H., Zangari, M., Yoon, D. and Yu, S.M. Visualizing collagen proteolysis
by peptide hybridization: From 3D cell culture to in vivo imaging.
Biomaterials, 2018.
-
Zangari, M., Yoo, H., Shin, I.J., Yoon, D.
and Suva, L.J. Surgical thyroparathyroidectomy prevents progression of 5TGM1
murine multiple myeloma in vivo. Journal of Bone Oncology, 2018.
-
Johann, D.J., Steliga, M.A., Shin, I.J.,
Yoon, D., Arnaoutakis, K., Hutchins, L.F., Liu, M., Liem, J., Walker, K.,
Pereira, A., Yang, M.Q., Jeffus, S.K., Peterson, E. and Xu, J. Liquid biopsy
and its role in an advanced clinical trial for lung cancer. Experimental
Biology and Medicine, 2018.
-
Zangari, M., Yoo, H., Shin, I.J., Kim, B.,
Edmondson, R., Morgan, G.J., Suva, L.J. and Yoon, D. Thymic PTH Increases After
Thyroparathyroidectomy in C57BL/KaLwRij Mice. Endocrinology, 2018.
-
Mohan, M., Samant, R., Yoon, D., Buros, A.,
Branca, A., Montgomery, C.O., Nicholas, R.W., Suva, L.J., Morello, R.,
Thanendrarajan, S., Schinke, C., Yaccoby, S., van Rhee, F., Davies, F.E. and
Zangari, M. Extensive Remineralization of Large Pelvic Lytic Lesions Following
Total Therapy Treatment in Patients With Multiple Myeloma. Journal of Bone and
Mineral Research, 2017.
-
Zangari, M., Shin, I.J., Branca, A., Yoo,
H., Fallo, S., Davies, F.E., Hoffman, B., Fruchtman, S.M. and Yoon, D.
Rigosertib, a Pan RAS Inhibitor, Decreases Mouse and Human Myeloma Cell Growth
in Preclinical Models. Blood, 2016.
-
Branca, A., Buros, A., Yoon, D., Suva,
L.J., Weinhold, N., Rasche, L., Schinke, C., Thanendrarajan, S., Mohan, M.,
Harcourt, C., Davies, F.E., van Rhee, F., Morgan, G.J. and Zangari, M.
Daratumumab Single Agent and Daratumumab Plus Pomalidomide and Dexametasone in
Relapsed/Refractory Multiple Myeloma: A Real Life Retrospective Evaluation.
Blood, 2016.
-
Divoky, V., Song, J., Horvathova, M.,
Kralova, B., Votavova, H., Prchal, J. and Yoon, D. Delayed hemoglobin switching
and perinatal neocytolysis in mice with gain-of-function erythropoietin
receptor. Journal of Molecular Medicine, 2015.
-
Zangari, M., Yoo, H., Suva, L.J. and Yoon,
D. Thymus-Derived PTH (TPTH) Is Increased after Thyroparathyroidectomy in
C57BL6/Kalwrij Mice and Modulates Mouse Sensitivity to 5TGM1 Myeloma Cell Line.
Blood, 2015.
-
Song, J., Kralova, B., Horvathova, M.,
Yoon, D., Prchal, J. and Divoky, V. Polycythemia of Mice with Human
Gain-of-Function EPOR (mtHEPOR) Is Transiently Corrected in Perinatal Life in
Association with Low Epo and Increased Erythrocyte Phosphatidylserine Exposure.
Blood, 2015.
-
Song, J., Yoon, D., Christensen, R.D.,
Horvathova, M., Thiagarajan, P. and Prchal, J. HIF-mediated increased ROS from
reduced mitophagy and decreased catalase causes neocytolysis. Journal of
Molecular Medicine, 2015.
-
Jethava, Y., Pena, K., Yoon, D., Stein,
C.K. and Zangari, M. Bone Effect of Low Dose Bortezomib in Patients with
Relapsed/Refractory Multiple Myeloma. Journal of Hematology and Thromboembolic
Diseases, 2015.
-
Zangari, M., Stein, C., Yaccoby, S., Yoon,
D., Heuck, C., Jethava, Y.S., Johann, D.J., Khan, R., Papanikolaou, X., Van
Rhee, F., Davies, F.E., Morgan, G.J. and Barlogie, B. Higher Expressions of PTH
Receptor Type 1 and/or 2 in Bone Marrow Is Associated to Longer Survival in
Newly Diagnosed Myeloma Patients Enrolled in Total Therapy 3. Blood, 2014.
Personal Details
https://loop.frontiersin.org/people/1095071/overview
https://www.researchgate.net/profile/Donghoon-Yoon
WoS Researcher
ID: CKR-7364-2022